Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma

Abstract

The current study tests the hypothesis that chronic atrophic gastritis from hypochlorhydria in the gastrin-deficient mouse predisposes the stomach to gastric cancer. Gross morphology and histology of 12-month-old wild-type (WT), gastrin-deficient (G−/−) and somatostatin-deficient (SOM−/−) mice were examined. Parietal and G cells, Ki67, TUNEL, villin and MUC2 expression were analysed by immunohistochemistry. RUNX3 and STAT3 expression was analysed by Western blot. Anchorage-independent growth was determined by cell cluster formation in soft agar. Compared to the WT and SOM−/− mice, hypochlorhydric G−/− mice developed parietal cell atrophy, significant antral inflammation and intestinal metaplasia. Areas of metaplasia within the G−/− mouse stomach showed decreased RUNX3 expression with elevated MUC2 and villin expression. Cells isolated from the tumor grew in soft agar. However, the cells isolated from WT, nontransformed G−/− and SOM−/− gastric tissue did not form colonies in soft agar. Consistent with elevated antral proliferation, tumor tissue isolated from the G−/− mice showed elevated phosphorylated STAT3 expression. We then examined the mechanism by which STAT3 was constitutively expressed in the tumor tissue of the G−/− mice. We found that IFNγ expression was also significantly higher in the tumor tissue of G−/− mice compared to WT and SOM−/− animals. To determine whether STAT3 was regulated by IFNγ, MKN45 cells were cocultured with IFNγ or gastrin. IFNγ significantly stimulated phosphorylation of STAT3 in the MKN45 cell line, but not gastrin. Therefore, we show here that in the hypochlorhydric mouse stomach, the chronic gastritis, atrophy, metaplasia, dysplasia paradigm can be recapitulated in mice. Moreover, neoplastic transformation of the antral gastric mucosa does not require gastrin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

Abbreviations

WT:

wild-type mice

G−/−:

gastrin-deficient mice

SOM−/−:

somatostatin-deficient

G cells:

gastrin-expressing cells

H&E:

hematoxylin and eosin

G−/−M:

metaplastic tissue in gastrin-deficient mice

G−/−T:

tumor tissue in gastrin-deficient mice

References

  • Bacchi CE and Gown AM . (1991). Lab. Invest., 64, 418–424.

  • Bae SC and Choi JK . (2004). Oncogene, 23, 4336–4340.

  • Barrett NR . (1957). Surgery, 41, 881–894.

  • Blaser MJ and Parsonnet J . (1994). J. Clin. Invest., 94, 4–8.

  • Bowman T, Garcia R, Turkson J and Jove R . (2000). Oncogene, 19, 2474–2488.

  • Bretscher A and Weber K . (1979). Proc. Natl. Acad. Sci. USA, 76, 2321–2325.

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . (1999). Cell, 98, 295–303.

  • Correa P . (1992). Cancer Res., 52, 6735–6740.

  • Cover TL, Krishna US, Israel DA and Peek Jr RM . (2003). Cancer Res., 63, 951–957.

  • Darnell JEJ . (1997). Science, 277, 1630–1635.

  • Eaton KA, Ringler SR and Danon SJ . (1999). Infect. Immun., 67, 4594–4602.

  • Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC and Roa I . (1998). Gastroenterology, 114, 755–763.

  • Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A and Wang TC . (2003). Cancer Res., 63, 942–950.

  • Friis-Hansen L, Sundler F, Li Y, Gillespie PJ, Saunders TL, Greenson JK, Owyang C, Rehfeld JF and Samuelson LC . (1998). Am. J. Physiol., 274, G561–G568.

  • Harigai M, Hara M, Kawamoto M, Kawaguchi Y, Sugiura T, Tanaka M, Nakagawa M, Ichida H, Takagi K, Higami-Ohsako S, Shimada K and Kamatani N . (2004). Arthritis Rheum., 50, 2167–2177.

  • Johnson LR . (1977). Gastroenterology, 72, 788–792.

  • Judd LM, Alderman BM, Howlett M, Shulkes A, Dow C, Moverley J, Grail D, Jenkins BJ, Ernst M and Giraud AS . (2004). Gastroenterology, 126, 196–207.

  • Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M and Chiba T . (2004). Oncogene, 23, 4921–4929.

  • Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH and Kim JS . (2003). Am. J. Pathol., 163, 1551–1556.

  • Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ and Kang GH . (2004). Lab. Invest., 84, 479–484.

  • Koh TJ, Goldenring JR, Ito S, Mashimo I, Kopin AS, Varro A, Dockray GJ and Wang TC . (1997). Gastroenterology, 113, 1015–1025.

  • Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO and Park JG . (2004). Oncogene, 23, 6736–6742.

  • Kumble S, Omary MB, Fajardo LF and Triadafilopoulos G . (1996). Int. J. Cancer, 66, 48–54.

  • Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P and Rio MC . (1996). Science, 274, 259–262.

  • Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC and Ito Y . (2002). Cell, 109, 113–124.

  • Moore JH, Lesser EJ, Erdody DH, Natale RB, Orringer MB and Beer DG . (1994). Int. J. Cancer, 56, 487–493.

  • Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J and Jove R . (2002). Cancer Res., 62, 6659–6666.

  • Nagata A, Ito M, Iwata N, Kuno J, Takano H, Minowa O, Chihara K, Matsui T and Noda T . (1996). Proc. Natl. Acad. Sci. USA, 93, 11825–11830.

  • Osborn M, Mazzoleni G, Santini D, Marrano D, Martinelli G and Weber K . (1988). Virchows Arch. A. Pathol. Anat. Histopathol., 413, 303–312.

  • Overbergh L, Valckx D, Waer M and Mathieu C . (1999). Cytokine, 11, 305–312.

  • Peek Jr RM . (2002). J. Gastroenterol., 37 (Suppl. 13), 10–16.

  • Qing Y and Stark GR . (2004). J. Biol. Chem., 279, 41679–41685.

  • Semino-Mora C, Doi SQ, Marty A, Simko V, Carlstedt I and Dubois A . (2003). J. Infect. Dis., 187, 1165–1177.

  • Suter J, Hendry IR, Ndjountche L, Obholz K, Pru JK, Davis JS and Rueda BR . (2001). Biol. Reprod., 64, 1481–1486.

  • Torquati A, O’Rear L, Longobardi L, Spagnoli A, Richards WO and Daniel Beauchamp R . (2004). Surgery, 136, 310–316.

  • Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T . (2003). Cancer Sci., 94, 360–364.

  • Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ and Fox JG . (2000). Gastroenterology, 118, 36–47.

  • Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG and Dockray GJ . (1996). J. Clin. Invest., 98, 1918–1929.

  • Waterland RA and Jirtle RL . (2003). Mol. Cell. Biol., 23, 5293–5300.

  • Watson S, Durrant L and Morris D . (1989). Br. J. Cancer, 59, 554–558.

  • Xu X, Brodie SG, Yang X, Im YH, Parks WT, Chen L, Zhou YX, Weinstein M, Kim SJ and Deng CX . (2000). Oncogene, 19, 1868–1874.

  • Zavros Y, Rathinavelu S, Kao JY, Todisco A, Del Valle J, Weinstock JV, Low MJ and Merchant JL . (2003). Proc. Natl. Acad. Sci. USA, 100, 12944–12949.

  • Zavros Y, Rieder G, Ferguson A, Samuelson LC and Merchant JL . (2002a). Gastroenterology, 122, 119–133.

  • Zavros Y, Rieder G, Ferguson A, Samuelson LC and Merchant JL . (2002b). Am. J. Physiol. Gastrointest. Liver Physiol., 282, G175–G183.

Download references

Acknowledgements

This work was supported in part by Public Health Service Grants DK45729, DK61410 and DK62041 (JLM) and Michigan Gastrointestinal Peptide Research Center Pilot Feasibility Grant DK34933 (YZ). Rabbit gastrin antisera number 1296 was from the Center for Ulcer Research and Education Digestive Disease Research Center/RIA Core (University of California, Los Angeles) (Grant DK41301). RIAs were performed in the University of Michigan Gastrointestinal Peptide Research Center (DK34933). We also acknowledge the valuable assistance of Judy Poore for PAS/alcian blue staining, Kathy McClinchey (McClinchey Histology Lab, Inc., Stockbridge, MI, USA) for paraffin embedding and sectioning tissue.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juanita L Merchant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zavros, Y., Eaton, K., Kang, W. et al. Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma. Oncogene 24, 2354–2366 (2005). https://doi.org/10.1038/sj.onc.1208407

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208407

Keywords

This article is cited by

Search

Quick links